Maria Infantino, Boaz Palterer, Giulia Previtali, Maria-Grazia Alessio, Danilo Villalta, Teresa Carbone, Stefan Platzgummer, Giusi Paura, Caterina Castiglione, Martina Fabris, Giampaola Pesce, Brunetta Porcelli, Lucia Terzuoli, Maria-Romana Bacarelli, Marilina Tampoia, Luigi Cinquanta, Ignazio Brusca, Francesca Buzzolini, Maurizio Benucci, Matteo Tortora, Lorenzo Tronchin, Valerio Guarrasi, Paolo Soda, Mariangela Manfredi, Nicola Bizzaro
Anti-double-stranded DNA antibodies (anti-dsDNA) are considered a specific marker for systemic lupus erythematosus (SLE). Though the Farr technique was once the reference method for their detection, it has been almost entirely replaced by more recently developed assays. However, there is still no solid evidence of the commutability of these methods in terms of diagnostic accuracy and their correlation with the Crithidia luciliae immunofluorescence test (CLIFT). Anti-dsDNA antibody levels were measured in 80 subjects: 24 patients with SLE, 36 disease controls drawn from different autoimmune rheumatic diseases (14 systemic sclerosis, 10 Sjögren's syndrome, nine autoimmune myositis, three mixed connective tissue disease), 10 inflammatory arthritis and 10 apparently healthy blood donors by eight different methods: fluorescence enzyme immunoassay, microdot array, chemiluminescent immunoassay (two assays), multiplex flow immunoassay, particle multi-analyte technology immunoassay and two CLIFT...
September 29, 2022: Scandinavian Journal of Immunology